Zhitong Finance App News, Huayuan Biotech (300401.SZ) issued an announcement. Recently, the company and Guangzhou National Laboratory signed the “25-hydroxycholesterol New Drug Research and Development Project Cooperation Agreement”. The two sides agreed to cooperate to promote the research, registration, production and commercialization of broad-spectrum antiviral drugs such as 25-hydroxycholesterol and its precursor drugs by initiating the establishment of a joint venture. The candidate drug has significant market potential in the field of broad-spectrum antiviral drugs. The joint venture is led by the company for subsequent operations and holds no less than 51% of the shares.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.